Benzene Derivatives from Ink Lead to False Positive Results in Neonatal Hyperphenylalaninemia Screening with Ninhydrin Fluorometric Method

Predictive value of fluorometric method and tandem mass spectrometry for hyperphenylalaninemia and its subtypes in China: A systematic review and meta‑analysis

The present study aimed to conduct a comprehensive meta-analysis to assess the diagnostic value of fluorometric assays and tandem mass spectrometry (MS/MS) for hyperphenylalaninemia (HPA) and its subtypes. The PubMed, Embase and Cochrane Library databases were searched from inception to October 2023. The present study included studies that reported the newborn screening and genetic features of patients with HPA and excluded duplicate publications, studies without full text, studies with incomplete information, studies from which it was not possible to extract data, animal experiments, reviews and systematic reviews. STATA 15.1 was used to analyze the data. The pooled results revealed that 0.04% [95% confidence interval (CI): 0.019-0.069] of neonatal HPA fluorometric assays and MS/MS. The positive predictive value (PPV) of neonatal HPA screening using fluorometric assays and tandem mass spectrometry was 31.7% (95% CI: 19.6-45.2). Notably, the PPV of neonatal HPA screening using fluorometric assays was 8.3% (95% CI: 7.1-9.6), while the PPV of neonatal HPA screening using tandem mass spectrometry was 31.8% (95% CI: 16.4-49.4). Additionally, the pooled results showed that the incidence of tetrahydrobiopterin deficiency (BH4D) in HPA patients was 12.43% (95% CI: 3.28-25.75) and the incidence of phenylalanine hydroxylase deficiency (PAHD) in HPA patients was 88.65% (95% CI: 78.84-95.86). Newborn screening is an effective method for the early detection of HPA and MS/MS has a greater PPA than fluorometric assays for diagnosing HPA. In addition, in the screening of HPA, the proportion of HPA patients with PAHD was significantly higher than that of patients with BH4D.

The Impacts and Analysis of Individual and Social Risks of the Stochastic Emission of Benzene from Floating-Roof Tanks Using Response Surface Analysis and MPACT Model

In the present study, the researchers used an integrated approach composed of response surface analysis (RSM) and MPACT model to predict fatality rates caused by benzene emitted from floating-roof tanks. RSM scenarios were configured in Expert Design (version 7.0) software using the central composite design (CCD) method and five variables of wind speed, relative humidity, atmospheric temperature, failure diameter, and emission height were considered. Continuous Pasquill-Gifford Gaussian model was used to estimate the results of the RSM scenarios. The response values were considered for exposure concentrations above 50 ppm (slight damages), 150 ppm (moderate damage), and 1000 ppm (high damage). The analysis of individual and social risks for each scenario was done using the MPACT model in SAFETI program (version 8.22) by providing two variables of population characteristics and the frequency of tank wall failure. The results showed that atmospheric temperature, wind speed, failure diameter, and emission height have positive effects on the dispersion of the cloud of toxic benzene vapor with a concentration of 1000 ppm. Intolerable individual risk distances were estimated to be lower for indoor environments than for outdoor. Maximum distances of intolerable individual risks for the worst-case scenarios were estimated up to 2500 m from the emission point, which resulted from exposure to a concentration of 1000-ppm benzene. Results regarding the estimation of social risks showed that over 1600 fatalities should be expected under the worst-case scenarios. The three factors of high temperature, low wind speed, and low emission height play a major role in the occurrence of scenarios with the highest fatalities. High wind speed and high emission height were the most important factors in most scenarios with zero fatalities rate. Generally, the findings of this study show the necessity to provide an emergency response plan in the studied industry in both autumn and winter due to low wind speed. However, the coupling of the developed statistical models based on regional meteorological conditions with the MPACT model can help researchers to design an emergency response plan to deal with leakage incidents in petrochemical industries.

NeoSeq: a new method of genomic sequencing for newborn screening

Objective

To explore the clinical application of NeoSeq in newborn screening.

Methods

Based on the results obtained from traditional newborn screening (NBS) with tandem mass spectrometry (TMS), three cohorts were recruited into the present study: 36 true positive cases (TPC), 60 false-positive cases (FPC), and 100 negative cases. The dried blood spots of the infants were analyzed with NeoSeq, which is based on multiplex PCR amplicon sequencing.

Results

Overall, the sensitivity of NeoSeq was 55.6% (20/36) in the detection of TPC. NeoSeq detected disease-related genes in 20 of 36 TPC infants, while it could not identify these genes in eight children. Five cases (3.1%) with disease risk were additionally found in the FPC and NC cohorts. There was a significant difference in the diagnostic time between the two methods—10 days for NeoSeq vs. 43 days for traditional NBS.

Conclusions

NeoSeq is an economic genomic screening test for newborn screening. It can detect most inborn errors of metabolism, reduce the rate of false positive results, shorten the porting cycles, and reduce the screening cost. However, it is still necessary to further optimize the panel design and add more clinically relevant genomic variants to increase its sensitivity.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13023-021-02116-5.